OpenAI Makes Bold Healthcare Push With New Products and Hospital Partnerships
Key Takeaways
- ▸OpenAI launched three healthcare products in six months, including ChatGPT Health for consumers and a clinician-focused version, signaling healthcare as a core business vertical
- ▸Major hospital systems including Cedars-Sinai and HCA Healthcare are now OpenAI customers, with Sam Altman personally involved in enterprise sales calls
- ▸Over 230 million people globally use ChatGPT for health advice weekly, highlighting both the opportunity and the challenge of ensuring medical accuracy at scale
Summary
OpenAI is making a major strategic bet on healthcare, launching three new products in the past six months and securing customers among the country's largest hospital systems. The company has unveiled ChatGPT Health, a consumer-focused tool allowing patients to securely connect medical records and wellness apps, plus a dedicated version for clinicians. Nate Gross, former Doximity cofounder with medical credentials, now leads OpenAI's healthcare strategy, which the company positions as one of its most important verticals.
Sam Altman is personally involved in sales calls to major hospital systems, underscoring the company's commitment to this market. As of January 2024, enterprise healthcare customers include Cedars-Sinai Medical Center and HCA Healthcare. The company taps hundreds of doctors to improve ChatGPT's medical accuracy for over 230 million weekly users who seek health advice on the platform. OpenAI's models also power other health tech companies' clinical note-generation and lab result interpretation tools.
The push into healthcare comes as OpenAI faces mounting financial pressures and increased competition. The company reported a $39 billion net loss in 2025 (up from $5 billion in 2024) and faces rivals like Anthropic and Google in the healthcare AI space. With healthcare representing 18% of the U.S. economy, success could be transformational—but OpenAI must navigate concerns about accuracy, competition on pricing, and skepticism from enterprise healthcare providers.
- OpenAI faces intense competition from Anthropic and Google while managing significant financial losses, requiring healthcare success to support its valuation and IPO timeline
Editorial Opinion
OpenAI's aggressive healthcare push reflects the enormous opportunity but also the company's urgent need to diversify revenue streams beyond enterprise ChatGPT licenses. Healthcare is a high-stakes vertical where accuracy, trust, and regulatory compliance matter existentially—and OpenAI's success will ultimately hinge on whether its models can demonstrably improve outcomes rather than just automate workflows. The involvement of domain experts like Nate Gross and Altman's personal sales pitch suggest the company understands the stakes, but competition from well-positioned rivals and hospital cost pressures will determine whether OpenAI captures meaningful market share.
